After long preparations, Humira manufacturer AbbVie(ABBV) has been spun off from former parent Abbott Laboratories(ABT). Abbott shareholders will wake up to find one share of AbbVie in their account for every share of Abbott that they own.
We have covered the story, but not performed any deep analysis of either company. So let’s hear from you, readers. What do you think of Abbott? AbbVie? Let’s get a discussion going in the comments.
Disclosure: The author holds no position in any stock mentioned
AbbVie is going to do great……lots in the pipeline and is a sound investment.
Why haven’t I received my ABBV shares yet?
Good Question! Also the Jan 13 Puts at $64 disappeared…it looks like there was no options trading today. Anyone know why?
ABBV is not a great investment. I agree with the earlier assessment you posted from Morningstar. Too many unknowns in the next five years and those unknowns will weigh heavily on the shares’ upside potential.